# EDGAR Filing Document

**Accession Number:** 0001418135
**File Stem:** 0002086020-25-000001
**Filing Date:** 2025-9
**Character Count:** 7767
**Document Hash:** c7e1e62dfbc7c3cfdf9ace712e2df8f1
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0002086020-25-000001.hdr.sgml**: 20250917

**ACCESSION NUMBER**: 0002086020-25-000001

**CONFORMED SUBMISSION TYPE**: 3

**PUBLIC DOCUMENT COUNT**: 5

**CONFORMED PERIOD OF REPORT**: 20250826

**FILED AS OF DATE**: 20250917

**DATE AS OF CHANGE**: 20250917

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Lemire Olivier
- **CENTRAL INDEX KEY:** 0002086020

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-33829
- **FILM NUMBER:** 251320648

**MAIL ADDRESS:**
- **STREET 1:** 53 SOUTH AVENUE
- **CITY:** BURLINGTON
- **STATE:** MA
- **ZIP:** 01803
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Keurig Dr Pepper Inc.
- **CENTRAL INDEX KEY:** 0001418135
- **STANDARD INDUSTRIAL CLASSIFICATION:** BEVERAGES [2080]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 753258232
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 53 SOUTH AVENUE
- **CITY:** BURLINGTON
- **STATE:** MA
- **ZIP:** 01803
- **BUSINESS PHONE:** 877-208-9991

**MAIL ADDRESS:**
- **STREET 1:** 53 SOUTH AVENUE
- **CITY:** BURLINGTON
- **STATE:** MA
- **ZIP:** 01803

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Dr Pepper Snapple Group, Inc.
- **DATE OF NAME CHANGE:** 20080108

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CSAB Inc.
- **DATE OF NAME CHANGE:** 20071109

## Ex-24

![](poaol2001.jpg)

------

![](poaol2002.jpg)

------

![](poaol2003.jpg)

------

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3

### INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Lemire Olivier<br><sub>(Last) (First) (Middle)</sub><br>53 SOUTH AVENUE<br><sub>(Street)</sub><br>BURLINGTON, MA 01803<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>Keurig Dr Pepper Inc. [ KDP ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2025-08-26 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director   [ ] 10% Owner<br>[X] Officer (give title below)   [ ] Other (specify below)<br>_President, U.S. Coffee_ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities Beneficially Owned

---

|  |  |  |  |
| --- | --- | --- | --- |
| 1. Title of Security | 2. Amount of Securities Beneficially Owned | 3. Ownership Form | 4. Nature of Indirect Beneficial Ownership |
| Common Stock | 34337 | D |  |

---

## Table II - Derivative Securities Beneficially Owned

---

|  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Underlying Securities | 3. Title and Amount of Underlying Securities | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| Restricted Stock Unit | <sup>(1)</sup> | <sup>(1)</sup> | Common Stock | 9573 | $0 | D |  |
| Restricted Stock Unit | <sup>(2)</sup> | <sup>(2)</sup> | Common Stock | 14605 | $0 | D |  |
| Restricted Stock Unit | <sup>(3)</sup> | <sup>(3)</sup> | Common Stock | 12431 | $0 | D |  |
| Restricted Stock Unit | <sup>(4)</sup> | <sup>(4)</sup> | Common Stock | 4403 | $0 | D |  |
| Restricted Stock Unit | <sup>(5)</sup> | <sup>(5)</sup> | Common Stock | 1285 | $0 | D |  |
| Restricted Stock Unit | <sup>(6)</sup> | <sup>(6)</sup> | Common Stock | 1291 | $0 | D |  |
| Restricted Stock Unit | <sup>(7)</sup> | <sup>(7)</sup> | Common Stock | 3294 | $0 | D |  |
| Restricted Stock Unit | <sup>(8)</sup> | <sup>(8)</sup> | Common Stock | 17440 | $0 | D |  |

---

### Footnotes:

(1) Subject to certain vesting conditions and exceptions, these restricted stock units vest in four equal installments as follows: 25% on March 5, 2026; 25% on March 5, 2027; 25% on March 5, 2028, and 25% on March 5, 2029. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting.

(2) Subject to certain vesting conditions and exceptions, these restricted stock units vest in three installments as follows: 60% on March 4, 2027; 20% on March 4, 2028, and 20% on March 4, 2029. Eachrestricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon vesting.

(3) Subject to certain vesting conditions and exceptions, these restricted stock units vest in three installments as follows: 60% on March 1, 2026; 20% on March 1, 2027, and 20% on March 1, 2028. Eachrestricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon vesting.

(4) Subject to certain vesting conditions and exceptions, these restricted stock units vest in two equal installments as follows: 50% on March 2, 2026 and 50% of March 2, 2027. Each restricted stock unitrepresents a contingent right to receive one share of the Issuer's Common Stock upon vesting.

(5) Subject to certain vesting conditions and exceptions, these restricted stock units vest in two equal installments as follows: 50% on September 14, 2025 and 50% of September 14, 2026. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon vesting.

(6) Subject to certain vesting conditions and exceptions, these restricted stock units vest in full on March 3, 2026. Each restricted stock unit represents a contingent right to receive one share of the
Issuer's Common Stock upon vesting.

(7) Subject to certain vesting conditions and exceptions, these restricted stock units vest in full on September 15,  2025. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon vesting.

(8) Represents matching restricted stock units ("Matching RSUs") granted to the Reporting Person in connection with the Issuer's Elite Investment Program. These Matching RSUs vest in full on
November 16, 2026 ("Vesting Date"), subject to continued service with the Issuer and other vesting conditions. In addition, all or a portion of the Matching RSUs may be forfeited by the Reporting
Person if specified stock ownership requirements are not maintained to the Vesting Date. Each Matching RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting.

**Signature:** /s/ Mark Jackson, attorney in fact  
**Date:** 2025-09-17

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**